Congenital cytomegalovirus infection

Annals of the New York Academy of Sciences

Volumn 1205, Issue , 2010, Pages 144-147

  Syggelou, Angeliki ^a   Iacovidou, N ^a   Kloudas, S ^b   Christoni, Z ^c   Papaevangelou, V ^d  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b SOTIRIA GENERAL HOSPITAL   (Greece)

^c NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^d P AND A KYRIAKOU CHILDREN S HOSPITAL   (Greece)

Author keywords

congenital cytomegalovirus infection; deafness; psychomotor development

Indexed keywords

ANTIVIRUS AGENT; CIDOFOVIR; CYTOMEGALOVIRUS VACCINE; FOSCARNET; GANCICLOVIR; HYPERIMMUNE GLOBULIN; VALGANCICLOVIR;

AWARENESS; CHORIORETINOPATHY; CONFERENCE PAPER; CONGENITAL INFECTION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DIFFERENTIAL DIAGNOSIS; DISEASE TRANSMISSION; GONADAL DISEASE; HEALTH; HUMAN; HYDROCEPHALUS; KIDNEY DISEASE; KIDNEY FAILURE; NEUTROPENIA; NONHUMAN; OPTIC NERVE ATROPHY; PATHOGENESIS; PERCEPTION DEAFNESS; RETINITIS; STRABISMUS; THROMBOCYTOPENIA; VISUAL IMPAIRMENT; COMPLICATION; CYTOMEGALOVIRUS INFECTIONS; FEMALE; INFANT, NEWBORN, DISEASES; NEWBORN; PHYSIOLOGY; PREGNANCY;

CYTOMEGALOVIRUS;

CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; PREGNANCY;

EID: 77957033434     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2010.05649.x     Document Type: Conference Paper

References (22)

1. Numazaki, K. & S. Chiba. 1997. Current aspects of diagnosis and treatment of cytomegalovirus infection in infants. Clin. Diagn. Virol. 8: 169-181.
2. Griffiths, P.D. 2002. Strategies to prevent CMV infection in the neonate. Semin. Neonatol. 7: 293-299.
3. Pass, R.F. 2002. Cytomegalovirus infection. Pediatr. Rev. 23: 163-170.
4. Nelson, C.T. & G.J. Demmler. 1997. Cytomegalovirus infection in the pregnant mother, fetus, and the newborn infant. Clin. Perinatol. 24: 151-160.
5. Landolfo, S, M. Gariglio, G. Gribaudo & D. Lembo. 2003. The human cytomegalovirus. Pharmacol. Ther. 98: 269-297.
6. Leung, A.K., R.S. Sauve & H.D. Davies. 2003. Congenital cytomegalovirus infection. J. Natl. Med. Assoc. 95: 213-218.
7. Lagasse,N., I. Dhooge&P.Govaert. 2000. CongenitalCMVinfection and hearing loss. Acta Otorhinolaryngol. Belg. 54: 431-436.
8. Adler, S.P. 1999. Acquired cytomegalovirus infection. In Oskis Pediatrics: Principles and Practice. J.A. Mcmillan, C.D. DeAngelis & R.D. Feigin, Eds.: 1131-1143. Lippincott Williams &Wilkins. Philadelphia.
9. Gaytant, M.A., G.I. Rours, E.A. Steeger, et al. 2003. Congenital cytomegalovirus infection after recurrent infection: case reports and review of the literature. Eur. J. Pediatr. 162: 248-253.
10. Bryant, P., C. Morley, S. Garland & N. Curtis. 2002. Cytomegalovirus transmission from breast milk in premature babies: does it matter? Arch. Dis. Child. Fetal Neonatal. Ed. 87: F75-F77.
11. Stagno, S. 1995. Cytomegalovirus. In Infectious Diseases of the Fetus&Newborn Infant. J.S. Remington, J.O. Klein, Eds.: 312-353.W.B. Saunders Co. Philadelphia.
12. Ross, S.A., Fowler K.B., G. Ashrith, et al. 2006. Hearing loss in children with congenital cytomegalovirus infection born to mothers with preexisting immunity. J. Pediatr. 148: 332-336.
13. Wrightson, S. 2007. Universal newborn hearing screening. AAFP 75: 1349-1352.
14. Walter, S., C. Atkinson,M. Sharland, et al. 2008. Congenital cytomegalovirus: association between dried blood spot viral load and hearing loss. Arch. Dis. Child. Fetal Neonatal. Ed. 93: F280-F285.
15. Coats, D.K., J.G. Demmler, E.A. Paysse, et al. 2000. Ophthalmologic findings in children with congenital cytomegalovirus infection. J. AAPOS 4: 110-116.
16. Baumal, C.R., A.V. Levin, C.C. Kavalec, et al. 1996. Screening for cytomegalovirus retinitis in children. Arch. Pediatr. Adolesc. Med. 150: 1186-1192.
17. Tsutsui, Y., I. Kosugi & H. Kawasaki. 2005. Neuropathogenesis in cytomegalovirus infection: indication of the mechanisms using mouse models. Rev. Med. Virol. 15: 327-345.
18. Biron, K.K. 2006. Antiviral drugs for cytomegalovirus diseases. Antiviral Res. 71: 154-163.
19. Whitley, R.J., G. Cloud, W. Gruber, et al. 1997. Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J. Infect. Dis. 175: 1080-1086.
20. Spivey, J.F., B. Singleton, S. Sweet, et al. 2007. Safety and efficacy of prolonged cytomegalovirus prophylaxis with intravenous ganciclovir in pediatric and young adult lung transplant recipients. Pediatr. Transplant. 11: 312-318.
21. Cvetković, R.S. & K. Wellington. 2005. Valganciclovir: a review of its use in the management of CMV infection and disease in immunocompromised patients. Drugs 65: 859-878.
22. Nigro, G., S.P. Adler, R. La Torre & A.M. Best. 2005. Passive immunization during pregnancy for congenital cytomegalovirus infection. N. Engl. J. Med. 353: 1350-1362.